A Study to Investigate the Bioequivalence Test of DA-1229_01(A) at Fasting State

Randomized, Open Label, Single Oral Administration at Fasting State, 2 x 2 Crossover Study to Investigate the Bioequivalence Test of DA-1229_01(A)

A study demonstrates the bioequivalence of DA-1229_01(A) at Fasting State when compared with Sugamet sustained-release(SR) Tab 5/1000mg® in healthy adults

Inclusion Criteria:

• Adult patients over 19 years of age at the time of health examination
• Female patients who were confirmed to be not pregnant at health examination
• Patients without a history of mental illness in the past 5 years

Exclusion Criteria:

• Patients who have taken medications which could affect the results of the clinical trial in the past 10 days of participating in the clinical trial
• Patients with a congestive heart failure which requires medicinal treatment
• Patients who have made a whole blood donation in the past 2 months or an apheresis donation in the past 2 weeks of participating in the clinical trial
• Female patients who are lactating